DACAB Trial: Follow-up Extension

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

June 15, 2021

Conditions
Coronary Artery Bypass GraftingAntiplatelet Therapy
Interventions
OTHER

non-interventional

This study is a non-interventional, observational study. After completing 12-month treatment from DACAB trial, investigators would not make any interventions or impact on subjects' therapeutic strategy.

Trial Locations (6)

21002

Jiangsu Province Hospital, Nanjing

200025

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200092

Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200433

Changhai Hospital of Shanghai, Shanghai

210029

Nan Jing First Hospital, Nanjing

450003

Fuwai Central China Cardiovascular Hospital, Zhengzhou

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT03987373 - DACAB Trial: Follow-up Extension | Biotech Hunter | Biotech Hunter